Provided by Tiger Trade Technology Pte. Ltd.

Hca Healthcare Inc

432.65
+2.220.52%
Volume:321.43K
Turnover:138.23M
Market Cap:93.67B
PE:14.48
High:432.97
Open:430.50
Low:426.56
Close:430.43
52wk High:556.52
52wk Low:353.99
Shares:216.50M
Float Shares:143.73M
Volume Ratio:0.68
T/O Rate:0.22%
Dividend:3
Dividend Rate:0.69%
EPS(TTM):29.87
EPS(LYR):28.33
ROE:13631.68%
ROA:12.29%
PB:-14.10
PE(LYR):15.27

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Jul 09

HCA Healthcare Shares Fall After Barclays Downgrade

MT Newswires Live
·
Jul 09

Movement Alert|HCA Healthcare Falls 3.16% in Regular Trading, Health Care Facilities Sector Under Broad Pressure Amid Analyst Target Cuts

Market Focus
·
Jul 08

BofA Securities Adjusts HCA Healthcare Price Target to $435 From $415

MT Newswires Live
·
Jul 08

This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Benzinga
·
Jul 08

HCA Healthcare downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Jul 08

HCA Healthcare is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 07

HCA Healthcare price target lowered to $525 from $588 at Cantor Fitzgerald

TIPRANKS
·
Jul 07

HCA Healthcare Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 07

HCA Healthcare Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 03

HCA Healthcare Declares Q2 2026 Distribution of R$ 0.14 Per Unit, Payable July 6

Reuters
·
Jul 03

U.S. Stocks on the Move-silicom, Blue Owl, Intel

Reuters
·
Jul 03

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Jul 03

Movement Alert|HCA Healthcare Rises 3.04% in Regular Trading, CRISPR Gene Therapy Pediatric Study Published in NEJM Boosts Sentiment

Market Focus
·
Jul 02

HCA Healthcare Sets Final Dividend at BRL 0.14 Per BDR

Reuters
·
Jul 02

CRISPR Gene Editing Therapy Shows Groundbreaking Efficacy in Pediatric Patients

Deep News
·
Jun 30

HCA Healthcare announces research published in NEJM on CRISPR-based therapy

TIPRANKS
·
Jun 29

HCA Healthcare Says NEJM Study Shows Crispr Therapy Exa-cel Hits 12-month Endpoints in Children 5-11 with Sickle Cell, Beta Thalassemia

Reuters
·
Jun 29

HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in Crispr-based Therapy for Children

THOMSON REUTERS
·
Jun 29

Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA)

Simply Wall St.
·
Jun 29